Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion.
We report on a patient who had a urothelial tumor with tri-differentiation into transitional squamous and adenocarcinoma after ingestion of 285 gm. cyclophosphamide during a 15-year-period. The possibility is again raised that the use of high doses of this drug over long periods may be associated with an increased incidence of carcinoma of the bladder. Frequent cystoscopic examinations may be warranted in patients who have received large cumulative amounts of the drug
D000230:Adenocarcinoma / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006417:Hematuria / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced* / Q000532:radiotherapy
D003520:Cyclophosphamide